NMC Says No Antibiotics Before Diagnostic Tests

New Delhi: No antibiotics should be given without diagnostic tests proving that their use is warranted. This is the directive by the National Medical Commission (NMC), which has released a set of prescription guidelines for doctors given that the use of antimicrobials has increased in recent years and the hurry to prescribe them to suppress a suspected infectious disease has led to antimicrobial resistance (AMR).

The NMC has sent its 156-page guidelines, ‘National Action Plan on Antimicrobial Resistance (NAP-AMR) Module for Prescribers’, to medical institutions for both teachers and senior residents.

This is a condition when microbes, which are exposed to high-grade antibiotics, become used to them over time and become resistant to them. This makes treating common infections difficult, increasing the risk of severe illness and death. This resistance also makes them ineffective for preventing secondary infection during “surgeries, chemotherapy and managing chronic infections,” say the guidelines. In short, the microbes become superbugs.

Since infections can be bacterial, viral, fungal or parasitic, the guidelines say that “identification of the clinical problem and making a differential diagnosis at the bedside will help in deciding whether to start or not to start any antimicrobial. The history should assess the risk of infection based on the symptoms and signs and the common patterns of presentation of different diseases such as upper respiratory tract infections (URTI), lower respiratory tract infection (LRTI), urinary tract infection (UTI), meningitis, diarrhoea, skin and soft tissue infections.”

The guidelines suggest a “syndromic approach” at first to classify patients. These include those with acute febrile illness and rash — for example, viral infections like dengue or malaria, bacterial infection like scarlet fever, other infections like Lyme disease, drug reactions and autoimmune diseases. The category called acute febrile illness with jaundice, applies to viral infections like hepatitis, bacterial infection like typhoid and biliary tract infections. The acute febrile illness with neurological involvement includes meningitis while acute febrile illness with respiratory syndrome includes flu and pneumonia. In the last category, the guidelines say, “Most of the respiratory illnesses do not require antimicrobials. Viral infections are self-limiting and treated symptomatically. However, if a patient of respiratory symptoms presents with expectoration and signs of septicaemia, pneumonia should be suspected. Sputum samples should be sent to the laboratory and empirical antibiotics may be initiated.”

In case of urinary tract infections, the guidelines recommend that “antimicrobials may be initiated empirically in situations like pregnancy, diabetes etc and can then be modified as per available reports.”

Apart from a detailed history of presenting infection, the guidelines say the clinician should go through history of any surgical, medical disorders and co-morbidities like diabetes as these may predispose an individual to infections. “Previous use of antibiotics in such situations may predispose for AMR in current illness,” the guidelines add.

The module emphasises the virtues of a detailed physical examination. “Finding a murmur on examination of cardiovascular system examination can point towards an infective endocarditis. Urinary tract infections (UTI) and skin infections like foot ulcers develop in diabetic patients. The collection of mid-stream urine samples in suspected UTI cases should be done.” For respiratory illnesses, “the decision to treat with antibiotics should be made by the presence of severity and laboratory report of sputum and culture examination,” says the new module.

The NMC also urges doctors to understand the proper technique of blood culture sampling and proper communication with the microbiology laboratory. “The positive culture reports must be conveyed rapidly to prescribers so that the therapeutic interventions can be made in the desired time frame,” it says. “The empiric antibiotic therapy must be limited to seriously ill patients. This choice should be based upon institutional/local antibiograms (these map how susceptible a series of organisms are to different antimicrobials). Choose the appropriate antibiotic based on clinical evaluation and most likely pathogen keeping the antibiogram in mind,” say the guidelines.

Related Posts

  • Pharma
  • April 28, 2025
  • 97 views
Gujrat leads pharma sector with record 183 new plants

Ahmedabad:  Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…

  • Pharma
  • April 28, 2025
  • 107 views
Doctor not liable for prescribing costly drug: HC

Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gujrat leads pharma sector with record 183 new plants

Gujrat leads pharma sector with record 183 new plants

Doctor not liable for prescribing costly drug: HC

Doctor not liable for prescribing costly drug: HC

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion